• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease.内皮血栓调节蛋白缺失可预测急性肠移植物抗宿主病对类固醇治疗的反应和生存率。
Haematologica. 2012 Nov;97(11):1674-7. doi: 10.3324/haematol.2011.061051. Epub 2012 Jun 11.
2
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system.类固醇难治性移植物抗宿主病:脆弱的内皮系统内的 T 细胞攻击。
Blood. 2011 Aug 11;118(6):1685-92. doi: 10.1182/blood-2011-02-334821. Epub 2011 Jun 2.
3
Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment.内皮脆弱性和内皮损伤与移植物抗宿主病的风险和对类固醇治疗的反应有关。
Biol Blood Marrow Transplant. 2013 Jan;19(1):22-7. doi: 10.1016/j.bbmt.2012.09.018. Epub 2012 Oct 3.
4
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.靶向整合素α4β7治疗类固醇难治性肠道移植物抗宿主病
Biol Blood Marrow Transplant. 2017 Jan;23(1):172-175. doi: 10.1016/j.bbmt.2016.10.009. Epub 2016 Oct 21.
5
C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.急性移植物抗宿主病诊断时 C 反应蛋白水平可预测激素耐药疾病、治疗相关死亡率和异基因造血干细胞移植后的总生存率。
Biol Blood Marrow Transplant. 2018 Mar;24(3):600-607. doi: 10.1016/j.bbmt.2017.10.025. Epub 2017 Oct 23.
6
Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.抗 α4β7 整联蛋白单克隆抗体(vedolizumab)治疗激素耐药性严重肠道急性移植物抗宿主病。
Bone Marrow Transplant. 2019 Jul;54(7):987-993. doi: 10.1038/s41409-018-0364-5. Epub 2018 Oct 24.
7
High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statin therapy.在未接受他汀类药物治疗的情况下,移植前血清硝酸盐水平高预示急性类固醇难治性移植物抗宿主病的风险。
Haematologica. 2014 Mar;99(3):541-7. doi: 10.3324/haematol.2013.090209. Epub 2013 Oct 18.
8
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.443例患者对作为急性移植物抗宿主病主要治疗方法的类固醇的反应:分级系统比较
Biol Blood Marrow Transplant. 2002;8(7):387-94. doi: 10.1053/bbmt.2002.v8.pm12171485.
9
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.重组人可溶性肿瘤坏死因子受体融合蛋白用于异基因造血干细胞移植后类固醇难治性移植物抗宿主病的治疗。
Am J Hematol. 2007 Jan;82(1):45-52. doi: 10.1002/ajh.20752.
10
Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.患有和未患有急性移植物抗宿主病的骨髓移植受者中的内皮细胞标志物
Bone Marrow Transplant. 1997 May;19(9):909-14. doi: 10.1038/sj.bmt.1700767.

引用本文的文献

1
Endothelial Activation and Stress Index (EASIX): A Prognostic Marker for Mortality After Acute Graft-Versus-Host Disease and Endothelial Complications.内皮激活与应激指数(EASIX):急性移植物抗宿主病及内皮并发症后死亡率的预后标志物。
Methods Mol Biol. 2025;2907:85-89. doi: 10.1007/978-1-0716-4430-0_4.
2
PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs.过氧化物酶体增殖物激活受体 γ 在动脉粥样硬化性血管内皮功能障碍中的作用:调节化合物和 PTMs。
Int J Mol Sci. 2023 Sep 24;24(19):14494. doi: 10.3390/ijms241914494.
3
EASIX-1year and late mortality after allogeneic stem cell transplantation.异基因干细胞移植后 EASIX-1 年和晚期死亡率。
Blood Adv. 2023 Sep 26;7(18):5374-5381. doi: 10.1182/bloodadvances.2022008617.
4
Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via α-ketoglutarate.活化蛋白 C 通过 α-酮戊二酸调节 T 细胞代谢和表观遗传 FOXP3 的诱导。
Blood Adv. 2023 Sep 12;7(17):5055-5068. doi: 10.1182/bloodadvances.2023010083.
5
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.急性移植物抗宿主病患者血清作用下,依激素反应的内皮细胞差异蛋白表达。
J Cell Mol Med. 2023 May;27(9):1227-1238. doi: 10.1111/jcmm.17712. Epub 2023 Apr 4.
6
Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.内皮细胞功能障碍:异基因干细胞移植结局的关键决定因素。
Bone Marrow Transplant. 2021 Oct;56(10):2326-2335. doi: 10.1038/s41409-021-01390-y. Epub 2021 Jul 12.
7
EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients.EASIX 用于预测住院 SARS-CoV-2 感染患者的结局。
Front Immunol. 2021 Jun 23;12:634416. doi: 10.3389/fimmu.2021.634416. eCollection 2021.
8
Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?同种异体造血干细胞移植后内皮起源早期并发症的生物标志物:它们具有潜在的临床作用吗?
Front Immunol. 2021 May 19;12:641427. doi: 10.3389/fimmu.2021.641427. eCollection 2021.
9
Endothelial damage and dysfunction in acute graft-versus-host disease.急性移植物抗宿主病中的内皮损伤与功能障碍
Haematologica. 2021 Aug 1;106(8):2147-2160. doi: 10.3324/haematol.2020.253716.
10
Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.地夫可特可抑制供者白细胞与内皮细胞的相互作用,并可预防急性移植物抗宿主病。
J Cell Mol Med. 2020 Jul;24(14):8031-8044. doi: 10.1111/jcmm.15434. Epub 2020 Jun 10.

本文引用的文献

1
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system.类固醇难治性移植物抗宿主病:脆弱的内皮系统内的 T 细胞攻击。
Blood. 2011 Aug 11;118(6):1685-92. doi: 10.1182/blood-2011-02-334821. Epub 2011 Jun 2.
2
The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation.血管新生及其抑制在异基因造血干细胞移植中的重要性。
Blood. 2011 Apr 21;117(16):4181-9. doi: 10.1182/blood-2010-10-312934. Epub 2011 Jan 21.
3
Graft-versus-host disease treatment: predictors of survival.移植物抗宿主病治疗:生存预测因素。
Biol Blood Marrow Transplant. 2010 Dec;16(12):1693-9. doi: 10.1016/j.bbmt.2010.05.019. Epub 2010 Jun 9.
4
Regression modeling of competing risk using R: an in depth guide for clinicians.使用 R 进行竞争风险回归建模:临床医生的深入指南。
Bone Marrow Transplant. 2010 Sep;45(9):1388-95. doi: 10.1038/bmt.2009.359. Epub 2010 Jan 11.
5
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.异基因造血干细胞移植后结局的风险评分:一项回顾性分析
Cancer. 2009 Oct 15;115(20):4715-26. doi: 10.1002/cncr.24531.
6
Pathology of graft-versus-host disease in the gastrointestinal tract.胃肠道移植物抗宿主病的病理学
Hum Pathol. 2009 Jul;40(7):909-17. doi: 10.1016/j.humpath.2009.04.001.
7
Graft-versus-host disease.移植物抗宿主病
Lancet. 2009 May 2;373(9674):1550-61. doi: 10.1016/S0140-6736(09)60237-3. Epub 2009 Mar 11.
8
Vascular endothelium and graft-versus-host disease.血管内皮与移植物抗宿主病
Best Pract Res Clin Haematol. 2008 Jun;21(2):129-38. doi: 10.1016/j.beha.2008.02.003.
9
Competing risk analysis using R: an easy guide for clinicians.使用R进行竞争风险分析:临床医生简易指南
Bone Marrow Transplant. 2007 Aug;40(4):381-7. doi: 10.1038/sj.bmt.1705727. Epub 2007 Jun 11.
10
Novel strategies for steroid-refractory acute graft-versus-host disease.类固醇难治性急性移植物抗宿主病的新策略。
Curr Opin Hematol. 2005 Jan;12(1):40-4. doi: 10.1097/01.moh.0000148763.12733.bb.

内皮血栓调节蛋白缺失可预测急性肠移植物抗宿主病对类固醇治疗的反应和生存率。

Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease.

机构信息

Institute of Pathology, University Hospital Heidelberg, Freiburg, Germany.

出版信息

Haematologica. 2012 Nov;97(11):1674-7. doi: 10.3324/haematol.2011.061051. Epub 2012 Jun 11.

DOI:10.3324/haematol.2011.061051
PMID:22689672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3487439/
Abstract

Steroid-refractory graft-versus-host disease causes significant morbidity and mortality after allogeneic stem cell transplantation. The pathomechanism of steroid resistance is currently not understood, but it has been suggested that endothelial cell dysfunction plays a role. Endothelial thrombomodulin was quantified along with histological markers of epithelial damage and cytotoxic T cells in colon biopsies from 51 allografted patients, and retrospectively correlated with response to steroids and survival. Loss of endothelial thrombomodulin was the strongest predictor of response to steroids (P=0.02) and nonrelapse mortality (P=0.01) in multivariate analyses adjusting for T-cell infiltrates, histological grading, vessel density, disease status, donor type, and conditioning therapy. Our data provide evidence that at disease onset, loss of endothelial thrombomodulin expression rather than excessive T-cell infiltration associates with steroid-refractory graft-versus-host disease and mortality. Prospective histological investigations are now warranted to improve diagnosis and prognostication of this core complication of stem cell transplantation.

摘要

激素难治性移植物抗宿主病(GVHD)是异基因造血干细胞移植后导致发病率和死亡率显著增加的主要原因。目前尚不清楚激素抵抗的发病机制,但有研究表明内皮细胞功能障碍可能发挥了作用。本研究通过对 51 例异基因移植患者的结肠活检组织进行分析,检测了组织学上皮损伤和细胞毒性 T 细胞的同时,还定量分析了内皮血栓调节蛋白,并回顾性分析了其与激素反应和生存之间的关系。多变量分析调整 T 细胞浸润、组织学分级、血管密度、疾病状态、供者类型和预处理治疗后,内皮血栓调节蛋白丢失是激素反应(P=0.02)和非复发死亡率(P=0.01)的最强预测因子。我们的数据提供了证据表明,在疾病发作时,内皮血栓调节蛋白表达缺失而不是过度的 T 细胞浸润与激素难治性移植物抗宿主病和死亡率相关。现在需要进行前瞻性的组织学研究,以改善对干细胞移植这一核心并发症的诊断和预后判断。